4.3 Article

Indole curcumin combats metastatic HBV-positive hepatocellular carcinoma by inhibiting cell proliferation, migration, and matrix metalloproteinase-9 activity

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Oncology

The metabolism of cancer cells during metastasis

Gabriele Bergers et al.

Summary: This review discusses the metabolic rewiring in cancer cells during the metastatic cascade and the distinct metabolic features of primary tumors and metastases. Metastasis is the leading cause of death in most cancer patients, and targeting metastatic seeding and colonization remains a significant challenge. Adjusting metabolism may provide therapeutic opportunities to prevent or reduce metastasis, and targeting the new metabolic traits in established metastases could lead to their eradication.

NATURE REVIEWS CANCER (2021)

Review Biochemistry & Molecular Biology

A Review of Curcumin and Its Derivatives as Anticancer Agents

Mhd Anas Tomeh et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Oncology

Causes of death among cancer patients

N. G. Zaorsky et al.

ANNALS OF ONCOLOGY (2017)

Article Medicine, Research & Experimental

In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione

Shamim Akhtar Sufi et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Review Biotechnology & Applied Microbiology

Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B

Guo-Hua Qiu et al.

CYTOTECHNOLOGY (2015)

Article Physiology

Cell Migration

Xavier Trepat et al.

COMPREHENSIVE PHYSIOLOGY (2012)

Article Oncology

Curcumin Decreases Survival of Hep3B Liver and MCF-7 Breast Cancer Cells

Mareike Stroefer et al.

STRAHLENTHERAPIE UND ONKOLOGIE (2011)

Review Pharmacology & Pharmacy

CURCUMIN THERAPEUTIC PROMISES AND BIOAVAILABILITY IN COLORECTAL CANCER

A. Shehzad et al.

DRUGS OF TODAY (2010)

Review Biochemical Research Methods

Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors

PAM Snoek-van Beurden et al.

BIOTECHNIQUES (2005)

Review Gastroenterology & Hepatology

The prognostic molecular markers in hepatocellular carcinoma

LX Qin et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2002)